Pages that link to "Item:Q1430351"

The following pages link to Optimal control applied to immunotherapy (Q1430351):

Displaying 50 items.

• Optimal control in a model of dendritic cell transfection cancer immunotherapy (Q263587) (← links)
• Optimal multitherapy strategy in mathematical model of dynamics of the number of nonuniform tumor cells (Q357808) (← links)
• Optimal controls for a mathematical model of tumor-immune interactions under targeted chemotherapy with immune boost (Q378951) (← links)
• Bifurcation analysis of a delayed mathematical model for tumor growth (Q502046) (← links)
• A switching control law approach for cancer immunotherapy of an evolutionary tumor growth model (Q503846) (← links)
• Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics (Q662618) (← links)
• A computational approach for understanding immune response to multiple epitopes based on optimal control formulation (Q720343) (← links)
• Failure of antibiotic treatment in microbial populations (Q843321) (← links)
• Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model (Q1625717) (← links)
• Optimization of combined leukemia therapy by finite-dimensional optimal control modeling (Q1682981) (← links)
• Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine (Q1713207) (← links)
• The combined effects of optimal control in cancer remission (Q1732198) (← links)
• Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors (Q1743540) (← links)
• Stochastic optimal therapy for enhanced immune response (Q1886329) (← links)
• Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach (Q2120664) (← links)
• Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach (Q2131714) (← links)
• Optimal control with isoperimetric constraint for chemotherapy of tumors (Q2170964) (← links)
• Chemotherapy and immunotherapy for tumors: a study of quadratic optimal control (Q2187010) (← links)
• Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison (Q2192671) (← links)
• A cellular automata model of tumor-immune system interactions (Q2195073) (← links)
• Optimization of interleukin-21 immunotherapeutic strategies (Q2211591) (← links)
• Cancer immunotherapy, mathematical modeling and optimal control (Q2219776) (← links)
• Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model (Q2223666) (← links)
• Optimal control analysis of a leukemia model under imatinib treatment (Q2228752) (← links)
• Optimal control strategies for a two-group epidemic model with vaccination-resource constraints (Q2287705) (← links)
• Immune therapeutic strategies using optimal controls with \(L^{1}\) and \(L^{2}\) type objectives (Q2410370) (← links)
• Modeling pancreatic cancer dynamics with immunotherapy (Q2417545) (← links)
• Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy (Q2422280) (← links)
• A set-valued approach to control immunotherapy (Q2426087) (← links)
• Smooth solutions of the Hamilton-Jacobi-Bellman equation in a mathematical model of optimal treatment of viral infections (Q2429699) (← links)
• Determination of the optimal therapeutic protocols in cancer immunotherapy (Q2455540) (← links)
• Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls (Q2455569) (← links)
• Optimal control of the dynamics of a tumor growth model with Hollings' type-II functional response (Q2514073) (← links)
• Optimal control of effector-tumor-normal cells dynamics in presence of adoptive immunotherapy (Q2671040) (← links)
• An optimal control problem of immuno-chemotherapy in presence of gene therapy (Q2671158) (← links)
• Quadratic and linear controls developing an optimal treatment for the use of BCG immunotherapy in superficial bladder cancer (Q2800475) (← links)
• A Mathematical Model of Gene Therapy for the Treatment of Cancer (Q2820390) (← links)
• Therapy strategy in tumour cells and immune system interaction mathematical model (Q2825318) (← links)
• Delay dynamics of cancer and immune cell model (Q2896945) (← links)
• (Q2954285) (← links)
• An optimal control approach to cancer treatment under immunological activity (Q3079974) (← links)
• Optimal control problem in an epidemic disease SIS model with stages and delays (Q3188739) (← links)
• Optimal control model of immunotherapy for autoimmune diseases (Q5004473) (← links)
• MODEL FOR TRANSMISSION AND OPTIMAL CONTROL OF ANTHRAX INVOLVING HUMAN AND ANIMAL POPULATION (Q5045123) (← links)
• The impact of infected T lymphocyte burst rate and viral shedding rate on optimal treatment scheduling in a human immunodeficiency virus infection (Q5050550) (← links)
• Optimal control analysis of combined chemotherapy-immunotherapy treatment regimens in a PKPD cancer evolution model (Q5050555) (← links)
• Tumor Control, Elimination, and Escape through a Compartmental Model of Dendritic Cell Therapy for Melanoma (Q5107198) (← links)
• A STRATEGY OF OPTIMAL EFFICACY OF T11 TARGET STRUCTURE IN THE TREATMENT OF BRAIN TUMOR (Q5230440) (← links)
• Synthesis of optimal control in a mathematical model of tumour–immune dynamics (Q5254096) (← links)
• STOCHASTIC DYNAMICS BETWEEN THE IMMUNE SYSTEM AND CANCER CELLS WITH ALLEE EFFECT AND IMMUNOTHERAPY (Q6090088) (← links)